Cannabis Law

In 2017 Lesotho became the first African country to legalise cannabis for medical purposes. Medical cannabis is regulated in terms of the Drugs of Abuse Act of 2008 and the regulations published thereunder namely the Drugs of Abuse (Cannabis) Regulations of 2018.

Albertus Kleingeld has played an advisory role in this regard. Kleingeld Attorneys has advised more than 26 multi-national companies on Cannabis Law, the regulatory framework, and the commercial application thereof.  As one of the founding members of the Phekoana Cannabis Association of Lesotho, all the initial meetings of the Association were chaired by Albertus Kleingeld.

Kleingeld Attorneys has had the privilege of being involved in the following transactions:  

• Bophelo Bio Science & Wellness pertaining to the Halo Acquisition 
• Advising Aphria: Medical Marijuana & Cannabis Oil Canada  in relation to the cannabis regulatory framework in Lesotho
• Advising the Pension Fund of Lesotho through Mergence Investment Managers with regards to Medigrow/ MG Health 
• Advising Verve Dynamics in obtaining regulatory approval 
• Advising Maluti Green-Med pertaining to debt and equity financing 
• Advising Hempvest Africa with regards to equity funding and corporate finance

The cannabis industry is characterized by collaboration and networks and we have developed a network of contacts on a global scale. We make these contacts available to our clients. 

Our experience in the issuing of licenses, regulatory compliance, and start-ups is extensive, and we have played a pivotal role in the cannabis landscape in Lesotho. Our team chairs the Cannabis Association. We advise clients globally and act as a liaison between international and local regulator.